Clik here to view.
Osimertinib Improves Progression-free Survival of EGFR-mutated Lung Cancer in...
Osimertinib improves progression-free survival compared to standard first line therapy in Asian patients with EGFR-mutated non-small-cell lung cancer (NSCLC). The findings are based on the Asian...
View ArticleClik here to view.
Smoke-Free Laws Reduce New Cases of Lung Cancer
New cases of lung cancer were reduced in communities with strong smoke-free workplace laws according to a recent study done in University of Kentucky BREATHE (Bridging Research Efforts and Advocacy...
View ArticleClik here to view.
Mix of Chemicals in Smoke and Environment Cause Lung Cancer
Some chemicals in cigarette smoke and industrial processes may be more dangerous than previously thought. Though most low molecular weight polycyclic aromatic hydrocarbons (LMW PAHs) have not been...
View ArticleClik here to view.
Surgery Remains To Be the Best Treatment For Early Stage Lung Cancer
Patients with early stage lung cancer live longer after they underwent lobectomy, the most common type of operation for the disease. Rather than a less extensive operation or radiation treatment the...
View ArticleClik here to view.
New Combination Therapy Improves Lung Cancer Patient Outcomes
A new drug combination therapy has been identified for non-small cell lung cancers. By combining two drugs, lung cancer patients response to immunotherapy can be improved, reveals a new study. Johns...
View ArticleClik here to view.
Combination Therapy Reduces Progression in Lung Cancer
A new combination therapy for the first line treatment of advanced non-squamous non-small-cell lung cancer (NSCLC) improves progression-free survival (PFS). "This is the first phase III trial to...
View ArticleClik here to view.
Genetic Mutation Key for Targeted Lung Cancer Therapy, Not Smoking History
Smokers are less likely than non-smokers to have lung cancers caused by targetable genetic changes. But a study published in the journal iClinical Cancer Research/i shows that when they do, smokers...
View ArticleClik here to view.
Bone Marrow Cells Promote Tumor Growth in Lung Cancer
A certain type of cell in the bone marrow known as bosteocalcin-expressing (Ocn+) osteoblasts,/b aid in the progression of tumor in patients with early stage lung cancer, reveals a new study. Bone...
View ArticleClik here to view.
EU to Start Planning for Lung Cancer Screening
Lung cancer is one of the most common cancers in the world. Leading lung cancer specialists are urging EU countries to take action to initiate life-saving lung cancer screening programmes as soon as...
View ArticleClik here to view.
Individualized, Risk-based Lung Cancer Screening can Save More Lives
Screening for lung cancer based on individual risk can save more lives than the current U.S. Preventive Services Task Force (USPSTF) guidelines, reveals a new study. The findings are published in...
View ArticleClik here to view.
Risk-based Lung Cancer Screening Lowers Quality of Life-years
Using a risk prediction tool, mortality of lung cancer patients can be reduced. But, risk-based screening is less efficient in terms of life-years saved, quality-adjusted life-years (QALYs), and...
View ArticleClik here to view.
Small-cell Lung Cancer Patients Do Not Receive Initial Treatment
In the U.S, small-cell lung cancer (SCLC) patients do not receive the initial standard-of-care treatment. They were also found to have lower overall survival rates, reveals a new study. The research...
View ArticleClik here to view.
Age Factor could be an Important Decision Maker in Lung Cancer Treatment
In early-stage Non-small Cell Lung Cancer (NSCLC), post-treatment recovery from surgical treatment might be difficult especially for older patients. In those situations, Stereotactic Body Radiation...
View ArticleClik here to view.
Lung Cancer Guideline Updated
Advancements in the molecular diagnostic testing of lung cancer have led to new treatments that can battle lung cancer, the most common cause of cancer death worldwide. To ensure that clinicians stay...
View ArticleClik here to view.
Exercise Program Reduces Complications Of Lung Cancer Surgery By Half
bHighlights/b ul class = "group-list punch-points" li Regular exercise before surgery for lung cancer reduces the complications by half. /li li The length of hospital stay for these patients can be...
View ArticleClik here to view.
Drug Resistance to Lung Cancer Can Now Be Detected
Molecular simulations can help understand the mechanism behind drug resistance to lung cancer medications. Scientists from the Universities of Bristol and Parma, Italy, have used molecular simulations...
View ArticleClik here to view.
Third-hand Smoke Ups Lung Cancer Risk in Mice
Exposure to third-hand smoke in early childhood may increase risk of lung cancer, revealed new study. Thirdhand smoke is a kind of toxic residue that lingers on indoor surfaces and in dust long after...
View ArticleClik here to view.
Novel Treatment for Lung Cancer - Removal of Insulin Receptors
bHighlights:/b ul class = "group-list punch-points" liSurgical removal of insulin receptor substrates 1 and 2 may stop lung cancer tumor growth. /li liThese insulin receptors are responsible for the...
View ArticleClik here to view.
Combination of Drugs to Combat Lung Cancer Identified
A bcombination of drugs to stop the growth of lung cancer may also stop resistance to treatments/b; research at the UT Southwestern's Simmons Cancer Center finds in a recent research and identifies...
View ArticleClik here to view.
New Immunotherapy Combination Benefits Lung Cancer Patients
New immunotherapy combination is surprisingly effective at controlling the lung cancer progression, revealed study published in The Lancet Oncology. Immunologist John Wrangle, M.D., of the Hollings...
View Article